⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 16, 2024Lara D. Veeken

Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study

Francesco Muratore Chiara Marvisi Giulia Cassone Caterina Ricordi Luigi Boiardi Pamela Mancuso Giulia Besutti Lucia Spaggiari Massimiliano Casali Stefania Croci Rexhep Durmo Annibale Versari Gabriella Di Tommaso Mariagrazia Catanoso Paolo Giorgi Rossi Carlo Salvarani

View Full Paper

Ask AI

Bookmark

Share

Abstract

To assess the maintenance of efficacy of one year of tocilizumab (TCZ) monotherapy after its discontinuation in large vessel-GCA (LV-GCA).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Muratore et al. (2024) studied this question.

synapsesocial.com/papers/68e5be8ab6db643587556de0 https://doi.org/10.1093/rheumatology/keae400

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Safety and Efficacy of Long-Term Tocilizumab in a Cohort of Patients with Giant Cell Arteritis: An Italian Monocentric Retrospective Study2024 · 2 citations
2OP0269 TREATMENT OF GIANT CELL ARTERITIS WITH ULTRA-SHORT GLUCOCORTICOIDS AND TOCILIZUMAB: RESULTS FROM THE EXTENSION TO 76 WEEKS2024
3AB1314 SAFETY AND EFFICACY OF LONG-TERM TOCILIZUMAB IN A COHORT OF PATIENTS WITH GIANT CELL ARTERITIS: AN ITALIAN MONOCENTRIC RETROSPECTIVE STUDY2024
4AB1329 COMPARATIVE EFFICACY AND SAFETY OF GLUCOCORTICOIDS, METHOTREXATE AND TOCILIZUMAB IN THE TREATMENT OF NEW-ONSET LARGE VESSEL GIANT CELL ARTERITIS2024
5OP0283 LONG-TERM EFFICACY OF TOCILIZUMAB MONOTHERAPY AFTER ULTRA-SHORT GLUCOCORTICOID ADMINISTRATION TO TREAT GIANT CELL ARTERITIS: THREE YEAR FOLLOW-UP OF THE GUSTO TRIAL2024 · 1 citations